Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to Stata DX
The startup will develop and commercialize cost-effective, highly sensitive and specific point-of-care diagnostics, applying a novel electrochemical sensor platform created at the Wyss Institute
